LY56110

Modify Date: 2024-01-10 10:32:19

LY56110 Structure
LY56110 structure
Common Name LY56110
CAS Number 26766-37-0 Molecular Weight 315.20
Density 1.296g/cm3 Boiling Point 438.3ºC at 760mmHg
Molecular Formula C17H12Cl2N2 Melting Point N/A
MSDS N/A Flash Point 251.5ºC

 Use of LY56110


LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study[1][2].

 Names

Name 5-[bis(4-chlorophenyl)methyl]pyrimidine
Synonym More Synonyms

 LY56110 Biological Activity

Description LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study[1][2].
Related Catalog
References

[1]. Lindstrom TD, et al. Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeys. Fundam Appl Toxicol. 1987;8(4):595-604.  

[2]. O'Neill LA, et al. Effect of estrogen inhibitors on conceptus estrogen synthesis and development in the gilt. Domest Anim Endocrinol. 1991;8(1):139-153.  

 Chemical & Physical Properties

Density 1.296g/cm3
Boiling Point 438.3ºC at 760mmHg
Molecular Formula C17H12Cl2N2
Molecular Weight 315.20
Flash Point 251.5ºC
Exact Mass 314.03800
PSA 25.78000
LogP 4.96360
Vapour Pressure 1.79E-07mmHg at 25°C
Index of Refraction 1.625

 Synthetic Route

~54%

LY56110 Structure

LY56110

CAS#:26766-37-0

Literature: Keenan, Martine; Abbott, Michael J.; Alexander, Paul W.; Armstrong, Tanya; Best, Wayne M.; Berven, Bradley; Botero, Adriana; Chaplin, Jason H.; Charman, Susan A.; Chatelain, Eric; Von Geldern, Thomas W.; Kerfoot, Maria; Khong, Andrea; Nguyen, Tien; McManus, Joshua D.; Morizzi, Julia; Ryan, Eileen; Scandale, Ivan; Thompson, R. Andrew; Wang, Sen Z.; White, Karen L. Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4189 - 4204

~26%

LY56110 Structure

LY56110

CAS#:26766-37-0

Literature: Taylor, Harold M.; Jones, C. David; Davenport, James D.; Hirsch, Kenneth S.; Kress, T.J.; Weaver, Dix Journal of Medicinal Chemistry, 1987 , vol. 30, # 8 p. 1359 - 1365

~%

LY56110 Structure

LY56110

CAS#:26766-37-0

Literature: Keenan, Martine; Abbott, Michael J.; Alexander, Paul W.; Armstrong, Tanya; Best, Wayne M.; Berven, Bradley; Botero, Adriana; Chaplin, Jason H.; Charman, Susan A.; Chatelain, Eric; Von Geldern, Thomas W.; Kerfoot, Maria; Khong, Andrea; Nguyen, Tien; McManus, Joshua D.; Morizzi, Julia; Ryan, Eileen; Scandale, Ivan; Thompson, R. Andrew; Wang, Sen Z.; White, Karen L. Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4189 - 4204

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

5-[(4-chlorophenyl)(4-chlorophenyl)methyl]pyrimidine
5-(Bis(4-chlorophenyl)methyl)pyrimidine